Kunin Audrey
Chief Product Officer
1 company
Insider Signal Score
40
WeakTrades Analyzed
9
12M Win Rate
33.3%
Avg 3M Return
-19.4%
Avg 12M Return
-28.9%
Kunin Audrey is a Chief Product Officer at NovaBay Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 6 buys and 3 sells.
Holdings by Company
NBYDec 6, 2022
Current Shares0
Value-
Net Activity+202.7K
Bought: 500.0KSold: 297.3K
Transaction History
Showing 8 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | NBY Novabay Pharmaceuticals, Inc. | Chief Product Officer | Sell | 1 | $1.81 | $1.81 | -100% | +20.0% | -83.6% | |
| Nov 21, 2022 | NBY Novabay Pharmaceuticals, Inc. | Chief Product Officer | Sell | 5,960 | $2.10 | $12,545.20 | -100% | +0.4% | -86.0% | |
| Sep 14, 2022 | NBY Novabay Pharmaceuticals, Inc. | Chief Product Officer | Sell | 291,368 | $0.16 | $46,094.42 | -58.3% | -70.7% | -90.7% | |
| Dec 3, 2021 | NBY Novabay Pharmaceuticals, Inc. | Chief Product Officer | Buy | 101,650 | $0.46 | $47,013.13 | +25.5% | -32.2% | -86.6% | |
| Dec 2, 2021 | NBY Novabay Pharmaceuticals, Inc. | Chief Product Officer | Buy | 262,369 | $0.48 | $124,887.64 | +192.9% | -36.2% | -87.4% | |
| Dec 1, 2021 | NBY Novabay Pharmaceuticals, Inc. | Chief Product Officer | Buy | 14,848 | $0.49 | $7,275.52 | +12.3% | -41.8% | -88.3% | |
| Nov 30, 2021 | NBY Novabay Pharmaceuticals, Inc. | Chief Product Officer | Buy | 30,000 | $0.46 | $13,800.00 | +32.9% | -36.8% | -87.9% | |
| Nov 23, 2021 | NBY Novabay Pharmaceuticals, Inc. | Chief Product Officer | Buy | 91,133 | $0.46 | $41,868.27 | +364.5% | -38.4% | -84.5% |